A PYMNTS Company

US: Trump taps Gottlieb to head FDA

By  |  March 12, 2017

The White House is expected to nominate Dr. Scott Gottlieb, a physician and conservative health policy expert, to lead the US Food and Drug Administration, sources familiar with the matter said.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    If confirmed by the Senate, Gottlieb would be in charge of implementing President Donald Trump’s plan to dramatically cut regulations governing food, drugs, cosmetics, dietary supplements and tobacco.

    Gottlieb, 44, is a resident fellow at the conservative American Enterprise Institute think tank and a partner at a large venture capital fund. He is a former FDA deputy commissioner who has frequently advocated a loosening of requirements needed for approval of new medical products.

    Gottlieb is well-known on Capitol Hill, where he has testified multiple times on hot-button health issues, including complex drug pricing matters, and is viewed favorably by the pharmaceuticals industry.

    Full Content: Bloomberg

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.